Mrs. Amy Marie Elit, AGACNP Nurse Practitioner - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 1751 E Harry Ave, Santa Ana, CA 92705 Phone: 877-896-7350 Fax: 800-340-7804 |
David Xavier Lopez, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1971 E 4th St Ste 200, Santa Ana, CA 92705 Phone: 888-959-5192 |
Liza Novenario Ros, NP Nurse Practitioner - Acute Care Medicare: Medicare Enrolled Practice Location: 1001 N Tustin Ave, Santa Ana, CA 92705 Phone: 714-953-2585 Fax: 714-953-3854 |
Mrs. Nicole Yvette Esquer, CPNP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2514 W Adams St, Santa Ana, CA 92704 Phone: 714-376-3427 |
Mr. Ronnie Alvarez Corona, NP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 1030 W Warner Ave, Santa Ana, CA 92707 Phone: 714-834-6900 |
Estelei Aquino Penuliar, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3401 W Sunflower Ave, Suite 250, Santa Ana, CA 92704 Phone: 714-619-8777 Fax: 714-619-3069 |
Angelika Panova, MHPNP-RN/ LMFT Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2030 E. 4th St., Ste. 140-f, Santa Ana, CA 92705 Phone: 714-887-3816 Fax: 951-215-0881 |
News Archive
Rates of premature mortality in the UK have been falling steadily, but the pace of decline is not as fast as in many other high-income countries, such as Australia. In that sense, the UK lags behind.
Scientists have revealed that a key molecule in breast and lung cancer cells can help switch off the cancers' ability to spread around the body.
The Southern Atlantic Healthcare Alliance (SAHA) has selected TeleTracking's RadarFind as the exclusive real-time locating provider for member hospitals. SAHA, which is comprised of 16 hospitals in North Carolina, chose RadarFind's real-time location system (RTLS) to enable their members to track medical equipment, patients and staff.
As President Obama's proposed budget heads to Congress, analysis of the breakdown of health reform - and whether it may still have a chance - continues.
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
› Verified 6 days ago